Device developers advance AI plans despite Trump uncertainty

The Trump administration’s policies have raised questions about how the FDA will regulate AI in medical devices.

The Trump administration’s policies have raised questions about how the FDA will regulate AI in medical devices.
Bundled payment models are growing in healthcare. Here is the blueprint for success.
Five keys to an effective tuition benefits program that supports your workforce.

Centene’s first-quarter results didn’t appear to quell investor concerns about volatility in the health insurance market.

Sen. Bill Cassidy’s report calls on Congress to improve program transparency, like requiring covered entities to show how they use 340B funds. Drug groups praised the findings, while hospitals argued the analysis was limited in scope.

The academic medical system said it had to act now to balance its budget amid financial challenges and uncertainties around federal funding.
The Franklin, Tennessee-based system continued to deleverage its portfolio during the quarter, boosted volumes and “held the line” on supply expenses, CEO Tim Hingtgen said.

In February, the insurer learned that Google Analytics shared data from its members with its advertising service from April 2021 through January 2024.

The California-based insurer’s results were “good enough,” one analyst said.

Wesley Burks’ last day will be Sept. 1. The health system has not yet named a permanent successor.